Michael James

Michael joined the Board in March 2022 as an independent director. He is currently a Director of OSPRI and Middlemore Clinical Trials.

Michael has previously held leadership roles in large organisations in the science and technology sector, including CFO for Plant & Food Research and Navman. He is a Chartered Accountant and a Chartered Member of the Institute of Directors.